NCT06825637

Brief Summary

The current project is a pilot study that seeks to compare the efficacy of Brief Behavioral Activation's treatment-as-usual that uses paper and pencil tools to Kandoo, a digital, gamified version of activity scheduling and self-monitoring, in a diverse sample of youth presenting with clinically significant symptoms of depression. We will compare the level of pre- and post-treatment depressive symptoms in participants, who will participate in an 8-week brief behavioral activation treatment protocol augmented with Kandoo to the pre- and post- treatment depressive symptoms in the control participants, who will participate in 8-week, treatment as usual, brief behavioral activation treatment protocol. To explore treatment response for the clinically significant symptoms, we will obtain pre- and post-treatment measures of depression, global functioning, and patient goals. During the standard clinical intake, additional information will be obtained, including detailed demographics, medical history, mental health status, and social skills. Beyond determining the overall effectiveness of BBA augmented with Kandoo, the sample diversity and availability of clinical behavioral observations of the participants will permit the development of explanatory models of predictive factors for BBA with Kandoo intervention outcomes.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
3mo left

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Mar 2025Aug 2026

First Submitted

Initial submission to the registry

February 10, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 13, 2025

Completed
16 days until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

February 13, 2025

Status Verified

February 1, 2025

Enrollment Period

5 months

First QC Date

February 10, 2025

Last Update Submit

February 10, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Depressive Symptoms and Global Functioning

    We will compare the pre- and post-treatment depressive symptoms and global functioning of participants, who completed BBA with Kandoo.

    8 weeks

Secondary Outcomes (1)

  • Improvement Factors

    8 weeks

Study Arms (2)

Brief Behavioral Activation with Kandoo

EXPERIMENTAL

Participants will use Kandoo to track their activities while receiving Brief Behavioral Activation treatment.

Device: Kandoo

Brief Behavioral Activation with traditional paper pencil tracking

NO INTERVENTION

Participants will use paper and pencil worksheets to track their activities while receiving Brief Behavioral Activation treatment.

Interventions

KandooDEVICE

Kandoo is an app that allows patients to track their activities in an engaging and gamified platform.

Brief Behavioral Activation with Kandoo

Eligibility Criteria

Age13 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age: 13.0 to 25:11 years old
  • Sex: male and female
  • Currently enrolled as a patient in the CMI clinic or Fort Health Virtual Outpatient Mental Health Clinic
  • Current clinical presentation must include symptoms of mild-to-moderate depression, two of which must be depressed/irritable mood most of the day and markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every day
  • Access to a smart device
  • Internet connectivity
  • Approval by parents and clinician for participants 13-17.11; approval by clinician for participants 18+

You may not qualify if:

  • eating disorder
  • manic episode (any current or history)
  • psychotic episode or psychotic disorder
  • active suicidality
  • homicidal
  • Any neurologic impairment that limits the ability to use a touch screen.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Child Mind Institute

New York, New York, 10022, United States

Location

Study Officials

  • Michael Milham, MD, PhD

    Child Mind Institute

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2025

First Posted

February 13, 2025

Study Start

March 1, 2025

Primary Completion

August 1, 2025

Study Completion (Estimated)

August 1, 2026

Last Updated

February 13, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations